Skip to main content
Top
Published in: BMC Urology 1/2012

Open Access 01-12-2012 | Research article

Increased expression of MMP-9 and IL-8 are correlated with poor prognosis of Bladder Cancer

Authors: Sabrina Thalita Reis, Katia Ramos M Leite, Luís Felipe Piovesan, José Pontes-Junior, Nayara Izabel Viana, Daniel Kanda Abe, Alexandre Crippa, Caio Martins Moura, Sanarelly Pires Adonias, Miguel Srougi, Marcos Francisco Dall’Oglio

Published in: BMC Urology | Issue 1/2012

Login to get access

Abstract

Background

Extracellular matrix homeostasis is strictly maintained by a coordinated balance between the expression of metalloproteinases (MMPs) and their inhibitors. The purpose of this study was to investigate whether the expression of MMP-9, MMP-2 and its specific inhibitors, are expressed in a reproducible, specific pattern and if the profiles are related to prognosis in Bladder Cancer (BC).

Methods

MMP-9, MMP-2 and its specific inhibitors expression levels were analyzed by quantitative real-time polymerase chain reaction (qRT-PCR) in fresh-frozen malignant tissue collected from 40 patients with BC submitted to transurethral resection of bladder. The control group consisted of normal bladder tissue from five patients who had undergone retropubic prostatectomy to treat benign prostatic hyperplasia.

Results

MMP-9 was overexpressed in 59.0 % of patients, and MMP-2, TIMP-1, TIMP-2, MMP-14, RECK and IL-8 was underexpressed in most of the patients. Regarding prognostic parameters we observed that high-grade tumors exhibited significantly higher levels of MMP-9 and IL-8 (p = 0.012, p = 0.003). Invasive tumors (pT1-pT2) had higher expression levels of MMP-9 than superficial tumors (pTa) (p = 0.026). The same was noted for IL-8 that was more expressed by invasive tumors (p = 0.015, p = 0.048). Most importantly tumor recurrence was related with higher levels of both MMP-9 (p = 0.003) and IL-8 (p = 0.005).

Conclusion

We have demonstrated that the overexpression of MMP-9 and higher expression of IL-8 are related to unfavorable prognostic factors of urothelial bladder cancer and tumor recurrence and may be useful in the follow up of the patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jemal A, Bray F, Center MM: Global Cancer Statistics, 2011. Cancer J Clin. 2011, 61: 69-90. 10.3322/caac.20107.CrossRef Jemal A, Bray F, Center MM: Global Cancer Statistics, 2011. Cancer J Clin. 2011, 61: 69-90. 10.3322/caac.20107.CrossRef
2.
go back to reference Jebar AH, Hurst CD, Tomlinson DC: FGFR3 and Ras gene mutationsare mutually exclusive genetic events in urothelial cell carcinoma. Oncogene. 2005, 24: 5218-5225. 10.1038/sj.onc.1208705.CrossRefPubMed Jebar AH, Hurst CD, Tomlinson DC: FGFR3 and Ras gene mutationsare mutually exclusive genetic events in urothelial cell carcinoma. Oncogene. 2005, 24: 5218-5225. 10.1038/sj.onc.1208705.CrossRefPubMed
3.
go back to reference Borden LS, Clark PE, Hall MC: Bladder Cancer. Curr Opin Oncol. 2005, 17: 275-280. 10.1097/01.cco.0000156985.47984.9e.CrossRefPubMed Borden LS, Clark PE, Hall MC: Bladder Cancer. Curr Opin Oncol. 2005, 17: 275-280. 10.1097/01.cco.0000156985.47984.9e.CrossRefPubMed
4.
go back to reference Toi M, Ishigaki S, Tominaga T: Metalloproteinases and tissue inhibitors of metalloproteinases. Breast Cancer Res Treat. 1998, 52: 113-124. 10.1023/A:1006167202856.CrossRefPubMed Toi M, Ishigaki S, Tominaga T: Metalloproteinases and tissue inhibitors of metalloproteinases. Breast Cancer Res Treat. 1998, 52: 113-124. 10.1023/A:1006167202856.CrossRefPubMed
5.
go back to reference Henriet P, Blavier L, Declerck YA: Tissue inhibitors of metalloproteinases (TIMP) in invasion and proliferation. APMIS. 1999, 107: 111-119. 10.1111/j.1699-0463.1999.tb01533.x.CrossRefPubMed Henriet P, Blavier L, Declerck YA: Tissue inhibitors of metalloproteinases (TIMP) in invasion and proliferation. APMIS. 1999, 107: 111-119. 10.1111/j.1699-0463.1999.tb01533.x.CrossRefPubMed
6.
go back to reference Nawrocki B, Polette M, Marchand V, Monteau M, Gillery P, Tournier JM: Expression of matrix metalloproteinases and their inhibitors in human bronchopulmonary carcinomas: quantificative and morphological analyses. Int J Cancer. 1997, 72: 556-564. 10.1002/(SICI)1097-0215(19970807)72:4<556::AID-IJC2>3.0.CO;2-P.CrossRefPubMed Nawrocki B, Polette M, Marchand V, Monteau M, Gillery P, Tournier JM: Expression of matrix metalloproteinases and their inhibitors in human bronchopulmonary carcinomas: quantificative and morphological analyses. Int J Cancer. 1997, 72: 556-564. 10.1002/(SICI)1097-0215(19970807)72:4<556::AID-IJC2>3.0.CO;2-P.CrossRefPubMed
7.
go back to reference Wallard MJ, Pennington CJ, Veerakumarasivam A, Burtt G, Mills IG, Warren A, Leung HY, Murphy G, Edwards DR, Neal DE, Kelly JD: Comprehensive profiling and localisation of the matrix metalloproteinases in urothelial carcinoma. Br J Cancer. 2006 Feb 27, 94: 569-577. 10.1038/sj.bjc.6602931.CrossRefPubMedPubMedCentral Wallard MJ, Pennington CJ, Veerakumarasivam A, Burtt G, Mills IG, Warren A, Leung HY, Murphy G, Edwards DR, Neal DE, Kelly JD: Comprehensive profiling and localisation of the matrix metalloproteinases in urothelial carcinoma. Br J Cancer. 2006 Feb 27, 94: 569-577. 10.1038/sj.bjc.6602931.CrossRefPubMedPubMedCentral
8.
go back to reference Eissa S, Ali-Labib R, Swellam M, Bassiony M, Tash F, El-Zayat TM: Noninvasive diagnosis of bladder cancer by detection of matrix metalloproteinases (MMP-2 and MMP-9) and their inhibitor (TIMP-2) in urine. Eur Urol. 2007, 52: 1388-1396. 10.1016/j.eururo.2007.04.006.CrossRefPubMed Eissa S, Ali-Labib R, Swellam M, Bassiony M, Tash F, El-Zayat TM: Noninvasive diagnosis of bladder cancer by detection of matrix metalloproteinases (MMP-2 and MMP-9) and their inhibitor (TIMP-2) in urine. Eur Urol. 2007, 52: 1388-1396. 10.1016/j.eururo.2007.04.006.CrossRefPubMed
9.
go back to reference Liabakk NB, Talbot I, Smith RA, Wilkinson K, Ballewill F: Matrix metalloproteinase 2 (MMP-2) and matrix metalloproteinase 9 (MMP-9) type IV collagenase in colorectal cancer. Cancer Res. 1996, 56: 190-196.PubMed Liabakk NB, Talbot I, Smith RA, Wilkinson K, Ballewill F: Matrix metalloproteinase 2 (MMP-2) and matrix metalloproteinase 9 (MMP-9) type IV collagenase in colorectal cancer. Cancer Res. 1996, 56: 190-196.PubMed
10.
go back to reference Kodate M, Kasai T, Hashimoto H, Yabumoto K, Iwata Y, Manobe H: Expression of matrix metalloproteinase (gelatinase) in T1 adenocarcinoma of the lung. Pathol Int. 1997, 47: 461-469. 10.1111/j.1440-1827.1997.tb04525.x.CrossRefPubMed Kodate M, Kasai T, Hashimoto H, Yabumoto K, Iwata Y, Manobe H: Expression of matrix metalloproteinase (gelatinase) in T1 adenocarcinoma of the lung. Pathol Int. 1997, 47: 461-469. 10.1111/j.1440-1827.1997.tb04525.x.CrossRefPubMed
11.
go back to reference Luca M, Huang S, Gershenwald JE, Singh RK, Reich R, Bar-Eli M: Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis. Am J Pathol. 1997, 151: 1105-1113.PubMedPubMedCentral Luca M, Huang S, Gershenwald JE, Singh RK, Reich R, Bar-Eli M: Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis. Am J Pathol. 1997, 151: 1105-1113.PubMedPubMedCentral
12.
go back to reference Yuan JP, Li T, Chen HB, Li ZH, Yang GZ, Hu BY, Shi XD, Tong SQ, Li YX, Guo XK: Analysis of gene expression profile in gastric cancer cells stimulated with Helicobacter pylori isogenic strains. J Med Microbiol. 2004, 53: 965-974. 10.1099/jmm.0.45634-0.CrossRefPubMed Yuan JP, Li T, Chen HB, Li ZH, Yang GZ, Hu BY, Shi XD, Tong SQ, Li YX, Guo XK: Analysis of gene expression profile in gastric cancer cells stimulated with Helicobacter pylori isogenic strains. J Med Microbiol. 2004, 53: 965-974. 10.1099/jmm.0.45634-0.CrossRefPubMed
13.
go back to reference Mian BM, Dinney CP, Bermejo CE, Sweeney P, Tellez C, Yang XD, Gudas JM, McConkey DJ, Bar-Eli M: Fully human anti-interleukin 8 antibody inhibits tumor growth in orthotopic bladder cancer xenografts via down-regulation of matrix metalloproteases and nuclear factor-kappaB. Clin Cancer Res. 2003, 9: 3167-3175.PubMed Mian BM, Dinney CP, Bermejo CE, Sweeney P, Tellez C, Yang XD, Gudas JM, McConkey DJ, Bar-Eli M: Fully human anti-interleukin 8 antibody inhibits tumor growth in orthotopic bladder cancer xenografts via down-regulation of matrix metalloproteases and nuclear factor-kappaB. Clin Cancer Res. 2003, 9: 3167-3175.PubMed
14.
go back to reference Cho NH, Shim HS, Rha SY, Kang SH, Hong SH, Choi YD, Hong SJ, Cho SH: Increased expression of matrix metalloproteinase 9 correlates with poor prognostic variables in renal cell carcinoma. Eur Urol. 2003, 44: 560-566. 10.1016/S0302-2838(03)00362-2.CrossRefPubMed Cho NH, Shim HS, Rha SY, Kang SH, Hong SH, Choi YD, Hong SJ, Cho SH: Increased expression of matrix metalloproteinase 9 correlates with poor prognostic variables in renal cell carcinoma. Eur Urol. 2003, 44: 560-566. 10.1016/S0302-2838(03)00362-2.CrossRefPubMed
15.
go back to reference Nastase A, Pâslaru L, Niculescu AM, Ionescu M, Dumitraşcu T, Herlea V, Dima S, Gheorghe C, Lazar V, Popescu I: Prognostic and predictive potential molecular biomarkers in colon cancer. Chirurgia (Bucur). 2011, 106 (2): 177-185. Nastase A, Pâslaru L, Niculescu AM, Ionescu M, Dumitraşcu T, Herlea V, Dima S, Gheorghe C, Lazar V, Popescu I: Prognostic and predictive potential molecular biomarkers in colon cancer. Chirurgia (Bucur). 2011, 106 (2): 177-185.
16.
go back to reference Takeuchi T, Hisanaga M, Nagao M, et al: The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an information prognostic indicator for colorectal cancer. Clin Cancer Res. 2004, 10: 5572-5579. 10.1158/1078-0432.CCR-03-0656.CrossRefPubMed Takeuchi T, Hisanaga M, Nagao M, et al: The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an information prognostic indicator for colorectal cancer. Clin Cancer Res. 2004, 10: 5572-5579. 10.1158/1078-0432.CCR-03-0656.CrossRefPubMed
17.
go back to reference Heppner KJ, Matrisian LM, Jensen RA, Rodgers WH: Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am J Pathol. 1996, 149: 273-282.PubMedPubMedCentral Heppner KJ, Matrisian LM, Jensen RA, Rodgers WH: Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am J Pathol. 1996, 149: 273-282.PubMedPubMedCentral
18.
go back to reference Cox G, Jones JL, Walker RA, Steward WP, O’Byrne KJ: Angiogenesis and non-small cell lung cancer. Lung Cancer. 2000, 27: 81-100. 10.1016/S0169-5002(99)00096-3.CrossRefPubMed Cox G, Jones JL, Walker RA, Steward WP, O’Byrne KJ: Angiogenesis and non-small cell lung cancer. Lung Cancer. 2000, 27: 81-100. 10.1016/S0169-5002(99)00096-3.CrossRefPubMed
19.
go back to reference Takahashi C, Sheng Z, Horan TP, et al: Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. Proc Natl Acad Sci U S A. 1998, 95: 13221-13226. 10.1073/pnas.95.22.13221.CrossRefPubMedPubMedCentral Takahashi C, Sheng Z, Horan TP, et al: Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. Proc Natl Acad Sci U S A. 1998, 95: 13221-13226. 10.1073/pnas.95.22.13221.CrossRefPubMedPubMedCentral
20.
go back to reference Sasahara RM, Takahashi C, Noda M: Involvement of the Sp1 site in ras-mediated down-regul ation of the RECK metastasis suppressor gene. Biochem Biophys Res Commun. 1999, 264: 668-675. 10.1006/bbrc.1999.1552.CrossRefPubMed Sasahara RM, Takahashi C, Noda M: Involvement of the Sp1 site in ras-mediated down-regul ation of the RECK metastasis suppressor gene. Biochem Biophys Res Commun. 1999, 264: 668-675. 10.1006/bbrc.1999.1552.CrossRefPubMed
21.
go back to reference Chang HC, Liu LT, Hung WC: Involvement of histone deacetylation in ras-induced down regulation of metastasis suppressor RECK. Cell Signal. 2004, 16: 675-679. 10.1016/j.cellsig.2003.11.001.CrossRefPubMed Chang HC, Liu LT, Hung WC: Involvement of histone deacetylation in ras-induced down regulation of metastasis suppressor RECK. Cell Signal. 2004, 16: 675-679. 10.1016/j.cellsig.2003.11.001.CrossRefPubMed
22.
go back to reference Hsu MC, Chang HC, Hung WC: HER-2/neu represses the metastasis suppressorRECK via ERK and Sp transcription factor to promote cell invasion. J Biol Chem. 2006, 281: 4718-4725.CrossRefPubMed Hsu MC, Chang HC, Hung WC: HER-2/neu represses the metastasis suppressorRECK via ERK and Sp transcription factor to promote cell invasion. J Biol Chem. 2006, 281: 4718-4725.CrossRefPubMed
23.
go back to reference Oh J, Takahashi R, Kondo S, et al: The membrane anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell. 2001, 107: 789-800. 10.1016/S0092-8674(01)00597-9.CrossRefPubMed Oh J, Takahashi R, Kondo S, et al: The membrane anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell. 2001, 107: 789-800. 10.1016/S0092-8674(01)00597-9.CrossRefPubMed
24.
go back to reference Chang CK, Hung WC, Chang HC: The Kazal motifs of RECK protein inhibit MMP-9 secretion and activity and reduce metastasis of lung cancer cells in vitro and in vivo. J Cell Mol Med 2008. 2008, 12: 12-ahead of print Chang CK, Hung WC, Chang HC: The Kazal motifs of RECK protein inhibit MMP-9 secretion and activity and reduce metastasis of lung cancer cells in vitro and in vivo. J Cell Mol Med 2008. 2008, 12: 12-ahead of print
Metadata
Title
Increased expression of MMP-9 and IL-8 are correlated with poor prognosis of Bladder Cancer
Authors
Sabrina Thalita Reis
Katia Ramos M Leite
Luís Felipe Piovesan
José Pontes-Junior
Nayara Izabel Viana
Daniel Kanda Abe
Alexandre Crippa
Caio Martins Moura
Sanarelly Pires Adonias
Miguel Srougi
Marcos Francisco Dall’Oglio
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Urology / Issue 1/2012
Electronic ISSN: 1471-2490
DOI
https://doi.org/10.1186/1471-2490-12-18

Other articles of this Issue 1/2012

BMC Urology 1/2012 Go to the issue